213 related articles for article (PubMed ID: 29541077)
41. Crosstalk between type II NKT cells and T cells leads to spontaneous chronic inflammatory liver disease.
Weng X; He Y; Visvabharathy L; Liao CM; Tan X; Balakumar A; Wang CR
J Hepatol; 2017 Oct; 67(4):791-800. PubMed ID: 28596110
[TBL] [Abstract][Full Text] [Related]
42. Invariant natural killer T cells play dual roles in the development of experimental autoimmune uveoretinitis.
Satoh M; Namba KI; Kitaichi N; Endo N; Kitamei H; Iwata D; Ohno S; Ishida S; Onoé K; Watarai H; Taniguchi M; Ishibashi T; Stein-Streilein J; Sonoda KH; Van Kaer L; Iwabuchi K
Exp Eye Res; 2016 Dec; 153():79-89. PubMed ID: 27720708
[TBL] [Abstract][Full Text] [Related]
43. alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells.
Kitamura H; Ohta A; Sekimoto M; Sato M; Iwakabe K; Nakui M; Yahata T; Meng H; Koda T; Nishimura S; Kawano T; Taniguchi M; Nishimura T
Cell Immunol; 2000 Jan; 199(1):37-42. PubMed ID: 10675273
[TBL] [Abstract][Full Text] [Related]
44. Interleukin-30 (IL27p28) alleviates experimental sepsis by modulating cytokine profile in NKT cells.
Yan J; Mitra A; Hu J; Cutrera JJ; Xia X; Doetschman T; Gagea M; Mishra L; Li S
J Hepatol; 2016 May; 64(5):1128-1136. PubMed ID: 26767500
[TBL] [Abstract][Full Text] [Related]
45. NKT cell responses to glycolipid activation.
Tefit JN; Davies G; Serra V
Methods Mol Biol; 2010; 626():149-67. PubMed ID: 20099127
[TBL] [Abstract][Full Text] [Related]
46. Extracellular cathepsin S and intracellular caspase 1 activation are surrogate biomarkers of particulate-induced lysosomal disruption in macrophages.
Hughes CS; Colhoun LM; Bains BK; Kilgour JD; Burden RE; Burrows JF; Lavelle EC; Gilmore BF; Scott CJ
Part Fibre Toxicol; 2016 Apr; 13():19. PubMed ID: 27108091
[TBL] [Abstract][Full Text] [Related]
47. Targeted delivery of α-galactosylceramide to CD8α+ dendritic cells optimizes type I NKT cell-based antitumor responses.
Macho-Fernandez E; Cruz LJ; Ghinnagow R; Fontaine J; Bialecki E; Frisch B; Trottein F; Faveeuw C
J Immunol; 2014 Jul; 193(2):961-9. PubMed ID: 24913977
[TBL] [Abstract][Full Text] [Related]
48. Widespread natural variation in murine natural killer T-cell number and function.
Rymarchyk SL; Lowenstein H; Mayette J; Foster SR; Damby DE; Howe IW; Aktan I; Meyer RE; Poynter ME; Boyson JE
Immunology; 2008 Nov; 125(3):331-43. PubMed ID: 18445005
[TBL] [Abstract][Full Text] [Related]
49. Modulation of acute graft-versus-host disease and chimerism after adoptive transfer of in vitro-expanded invariant Valpha14 natural killer T cells.
Kuwatani M; Ikarashi Y; Iizuka A; Kawakami C; Quinn G; Heike Y; Yoshida M; Asaka M; Takaue Y; Wakasugi H
Immunol Lett; 2006 Jul; 106(1):82-90. PubMed ID: 16806496
[TBL] [Abstract][Full Text] [Related]
50. Inhibitory function of NKT cells during early induction phase of nickel allergy.
Okuno H; Satoh M; Takeuchi E; Eshima K; Terashima M; Komotori J; Habu S; Tamauchi H; Iwabuchi K
Immunobiology; 2016 Jul; 221(7):833-8. PubMed ID: 26868431
[TBL] [Abstract][Full Text] [Related]
51. Cytokine production and migration of in vitro-expanded NK1.1(-) invariant Valpha14 natural killer T (Valpha14i NKT) cells using alpha-galactosylceramide and IL-2.
Ikarashi Y; Iizuka A; Heike Y; Yoshida M; Takaue Y; Wakasugi H
Immunol Lett; 2005 Nov; 101(2):160-7. PubMed ID: 16054231
[TBL] [Abstract][Full Text] [Related]
52. Cytokine-dependent modification of IL-12p70 and IL-23 balance in dendritic cells by ligand activation of Valpha24 invariant NKT cells.
Uemura Y; Liu TY; Narita Y; Suzuki M; Nakatsuka R; Araki T; Matsumoto M; Iwai LK; Hirosawa N; Matsuoka Y; Murakami M; Kimura T; Hase M; Kohno H; Sasaki Y; Ichihara Y; Ishihara O; Kikuchi H; Sakamoto Y; Jiao SC; Senju S; Sonoda Y
J Immunol; 2009 Jul; 183(1):201-8. PubMed ID: 19542431
[TBL] [Abstract][Full Text] [Related]
53. Pro-inflammatory activated Kupffer cells by lipids induce hepatic NKT cells deficiency through activation-induced cell death.
Tang T; Sui Y; Lian M; Li Z; Hua J
PLoS One; 2013; 8(12):e81949. PubMed ID: 24312613
[TBL] [Abstract][Full Text] [Related]
54. Autoreactive natural killer T cells: promoting immune protection and immune tolerance through varied interactions with myeloid antigen-presenting cells.
Hegde S; Fox L; Wang X; Gumperz JE
Immunology; 2010 Aug; 130(4):471-83. PubMed ID: 20465577
[TBL] [Abstract][Full Text] [Related]
55. Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide.
Osman Y; Kawamura T; Naito T; Takeda K; Van Kaer L; Okumura K; Abo T
Eur J Immunol; 2000 Jul; 30(7):1919-28. PubMed ID: 10940881
[TBL] [Abstract][Full Text] [Related]
56. α-Galactosylceramide-activated murine NK1.1(+) invariant-NKT cells in the myometrium induce miscarriages in mice.
Ichikawa T; Negishi Y; Shimizu M; Takeshita T; Takahashi H
Eur J Immunol; 2016 Aug; 46(8):1867-77. PubMed ID: 27198610
[TBL] [Abstract][Full Text] [Related]
57. Dendritic cell internalization of α-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses.
Choi DH; Kim KS; Yang SH; Chung DH; Song B; Sprent J; Cho JH; Sung YC
Cancer Res; 2011 Dec; 71(24):7442-51. PubMed ID: 22028323
[TBL] [Abstract][Full Text] [Related]
58. Glycolipid antigen induces long-term natural killer T cell anergy in mice.
Parekh VV; Wilson MT; Olivares-Villagómez D; Singh AK; Wu L; Wang CR; Joyce S; Van Kaer L
J Clin Invest; 2005 Sep; 115(9):2572-83. PubMed ID: 16138194
[TBL] [Abstract][Full Text] [Related]
59. Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis.
Burdin N; Brossay L; Kronenberg M
Eur J Immunol; 1999 Jun; 29(6):2014-25. PubMed ID: 10382765
[TBL] [Abstract][Full Text] [Related]
60. Connecting the dots: artificial antigen presenting cell-mediated modulation of natural killer T cells.
Sun W; Subrahmanyam PB; East JE; Webb TJ
J Interferon Cytokine Res; 2012 Nov; 32(11):505-16. PubMed ID: 23050947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
